SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sepracor, Inc., Subsidiary of Dainippon Sumitomo Pharma Co., Ltd., Fails to Win U.S. Approval of Epilepsy Drug STEDESA